Health Condition 1: N400- Benign prostatic hyperplasia without lower urinary tract symptoms
Conditions
Interventions
Intervention1: Majoon-e-Rasheedi
S. No. Drug Name Scientific Name Parts Used Quantity
Majoon Rasheedi containing Piper cubeba
Areca catechu Linn.
Eugenia coryophyllata
Pistacia lentiscus Linn.
Trachy
Sponsors
National Institute of Unani Medicine Bengaluru
Eligibility
Inclusion criteria
Inclusion criteria: Male patients about the age of 40 to 70 yrs. Patients having classical signs and symptoms of (BPH) like with increased urinary frequency, dysuria, urgency, dribbling, burning micturition, nocturia strains and incontinence of urine, etc. Prostate size - Grade I & II ultrasound based) USG findings (weight Flow rate >10 ml/s. Patients who will give their written informed consent and are able to do follow up.
Exclusion criteria
Exclusion criteria: Age below 40 years and above 70 years. P.S.A > 4 ng/ml Known case of stricture urethra. Active urinary tract infection. Carcinoma of prostate and abscess. Flow rate Patients of congenital deformities of the urogenital tract or any abdominoâ??pelvic pathology other than BPH. Systemic diseases such as Hypertension, Diabetes mellitus, tuberculosis, paralysis and Parkinsonism known cases of heart disease were excluded from the study. Previous B.P.H surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the prostate Volume Change in PVRU (Pre & Post) Improvement in Urine flow rate Qmax (Fortnightly) Decrease of (IPSS) International Prostate Symptom Score (Fortnightly) BPH Impact Index Timepoint: 45 days | — |
Secondary
| Measure | Time frame |
|---|---|
| ASSESMENT OF SAFETY PARAMETERS like CBP, ESR, AST, ALT, ALP, Blood Urea, Serum creatinine before and after the clinical trialTimepoint: 45 DAYS | — |
Countries
India
Contacts
Public ContactProf Mohd Aleemuddin Quamri
National Institute of Unani Medicine, Bengaluru
Outcome results
None listed